Authored By: Sarah
11 Jul 2024

 Bacterial Disease Diagnostics Market to grow by USD 4341.7 million between 2024-2028

According to a research report “ Bacterial Disease Diagnostics Market” by Product (Consumables, Instruments) End-user (Hospitals, Labs) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 4341.7 million at a CAGR of  6.78% during the forecast period. In the bacterial disease diagnostics market, digital health solutions are revolutionizing remote monitoring and POC tests. New diagnostic technologies, integrated with digital platforms, enhance test accuracy, convenience, and affordability. Home-based testing is now a reality, empowering patients with quick and effective results. Additionally, healthcare IT plays a pivotal role in managing infectious diseases, particularly in microbiology, by identifying resistant bacterial strains and facilitating targeted treatments..

Browse market data tables, figures, and in-depth TOC on “Bacterial Disease Diagnostics Market” by Product (Consumables, Instruments) End-user (Hospitals, Labs) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028.

 View detailed Table of Content- Click here

By Product, the Consumables segment is projected to dominate the market size in 2024.

The bacterial disease diagnostics market is experiencing significant growth due to the increasing prevalence of bacterial diseases and associated risk factors, particularly among the elderly population. With an estimated 300 to 500 million medical procedures utilizing diagnostic techniques taking place annually in the US, the hospital segment is poised for steady expansion. This growth is driven by the rising incidence of chronic diseases, the increasing number of medical imaging studies and surgical procedures, and technological advancements enhancing the reliability of diagnostic techniques.

By End-user, Hospitals  segment is expected to hold the largest market size for the year 2024.

In the Bacterial Disease Diagnostics Market, the consumables segment holds substantial value. This segment includes test kits, assays, and reagents essential for quantifying bacterial diseases. Repeat purchases of a diverse array of PCR consumables fuel market expansion. In-vitro diagnostics and academic institutions favor these consumables, leading to their increased significance. End-users consistently require reagents and buffers for conducting tests and experiments, necessitating a wide range of offerings from manufacturers to cater to varying testing applications.

North America is forecasted to hold the largest market size by region in 2024.

In the dynamic and competitive landscape of the Bacterial Disease Diagnostics Market, innovative solutions are paramount for identifying and addressing bacterial infections effectively. Leveraging advanced technologies such as molecular diagnostics and automation, market players are streamlining diagnostic processes, ensuring accurate results, and reducing turnaround times. This not only enhances patient care but also bolsters operational efficiency and profitability.

The Bacterial Disease Diagnostics Market t growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Abbott Laboratories
  • Accelerate Diagnostics Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Bruker Corp.
  • Danaher Corp.
  • DiaSorin SpA
  • EKF Diagnostics Holdings Plc
  • F. Hoffmann La Roche Ltd.
  • GENERI BIOTECH s.r.o.
  • Great Basin Scientific
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Revvity Inc.
  • Siemens AG
  • T2 Biosystems Inc.
  • Takara Bio Inc.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

In the rapidly evolving field of bacterial disease diagnostics, several key players are making significant strides. Thermo Fisher Scientific, Enasis Indonesia, Auro Biotechnologies, Biogenuix, Mologic, Torus Biosystems, and others are pioneering advancements in areas such as electron microscopy and molecular methods. These technologies are crucial for the detection and monitoring of bacterial diseases in various sectors, including aquaculture, where the health of species like Mackerel and Carp is vital. The CONNECT-C Grant Program, initiated by House of Sophrosyne, is a prime example of financial incentives and infrastructure schemes that support research and development in this domain. RNA Disease Diagnostics, a promising area, is also gaining traction, with applications in personalized medicine and infectious diseases, such as Human Immunodeficiency Virus. Omega Specialty Nurses play a vital role in the implementation and application of these diagnostic methods. Assumptions about the accuracy and accessibility of these technologies should be tempered, as ongoing research and advancements continue to shape the bacterial disease diagnostics market.

Market Research Overview

The Bacterial Disease Diagnostics Market encompasses a range of innovative solutions for detecting and managing various infectious illnesses. Key components of this market include antibiotic treatments, probiotics, and medical products. Water purification techniques are essential for ensuring the safety and nutritional value of food, which is another critical market segment. Nutritious food and health management programs are integral to maintaining overall wellness and preventing the spread of bacterial diseases. Molecular methods, such as electron microscopy, PCR, and next-generation sequencing, play a significant role in disease diagnosis. Companies like Torus Biosystems, I-Lab, BioMedomics, and Mylab Discovery Solutions provide advanced instruments and consumables for laboratory testing. PoC testing is increasingly popular due to its time efficiency and versatility. Budgetary concerns, operational barriers, and declining reimbursement scenarios are significant challenges in the market. However, funding schemes like the CONNECT-C Grant Program and financial incentives for personalized medicine and monitoring are driving growth. Infrastructure development and the evolution of high-throughput systems and automated platforms are also crucial factors. The market caters to various pathogens, including mosquito-borne diseases, syphilis, influenza, HPV, Neisseria gonorrhea, Chlamydia trachomatis, hospital-acquired infections, and other infectious diseases. Reliability, performance, and accuracy are essential considerations for testing needs. Cross-contamination, false-positives, and false-negatives are significant concerns, necessitating containment measures and stringent quality control.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio